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In the preovulatory ovarian follicle, mammalian oocytes are maintained in prophase meiotic arrest until the
luteinizing hormone (LH) surge induces reentry into the first meiotic division. Dramatic changes in the
somatic cells surrounding the oocytes and in the follicular wall are also induced by LH and are necessary for
ovulation. Here, we provide genetic evidence that LH-dependent transactivation of the epidermal growth factor
receptor (EGFR) is indispensable for oocyte reentry into the meiotic cell cycle, for the synthesis of the
extracellular matrix surrounding the oocyte that causes cumulus expansion, and for follicle rupture in vivo.
Mice deficient in either amphiregulin or epiregulin, two EGFR ligands, display delayed or reduced oocyte
maturation and cumulus expansion. In compound-mutant mice in which loss of one EGFR ligand is associated
with decreased signaling from a hypomorphic allele of the EGFR, LH no longer signals oocyte meiotic
resumption. Moreover, induction of genes involved in cumulus expansion and follicle rupture is compromised
in these mice, resulting in impaired ovulation. Thus, these studies demonstrate that LH induction of epidermal
growth factor-like growth factors and EGFR transactivation are essential for the regulation of a critical
physiological process such as ovulation and provide new strategies for manipulation of fertility.
The luteinizing hormone (LH) surge plays a central role in
promoting a cascade of events in ovarian preovulatory follicles
that are essential for the ovulation of a fertilizable oocyte.
Acting through LH-chorionic gonadotropin (LH-CG) recep-
tors (LHRs) (LHR is a member of the G protein-coupled
receptor superfamily encoded by Lhcgr), LH induces repro-
gramming of the gene expression profiles of follicular somatic
cells (theca and granulosa cells), changes in the secretory prop-
erties of the cumulus cells surrounding the oocyte and cumulus
expansion, oocyte reentry into the meiotic cell cycle, and fol-
licle rupture (7, 41). LHRs are highly expressed on the gran-
ulosa cells lining the antral cavity of preovulatory follicles (mu-
ral granulosa cells) and on the external theca cells that are in
continuity with the surrounding stroma. However, within pre-
ovulatory follicles, oocytes and cumulus cells that are pro-
foundly affected by the LH surge express few or no LHRs and
fail to respond when directly exposed to LH in vitro (37).
To explain how LH signals are propagated from the periph-
ery toward the cumulus oocyte complex (COC), a model has
been proposed whereby factors released by mural granulosa
cells function in an autocrine and paracrine manner to trans-
duce the LH effects within the follicle (34). Secretion of bio-
active growth factors from the oocyte to affect somatic cells is
well established (27, 30); conversely, the paracrine signals orig-
inating from the somatic cells and affecting oocytes have long
been sought but are largely unknown. Recently, we have pro-
posed that intrafollicular release of members of the epidermal
growth factor (EGF)-like family (34) may fulfill this role. LH
or human CG (hCG) induces the rapid and transient expres-
sion of Areg, Ereg, and Btc (encoding amphiregulin [AREG],
epiregulin [EREG], and betacellulin [BTC], respectively) in
mural granulosa cells of mouse (34) and rat preovulatory fol-
licles (1, 48) and in human granulosa cell cultures (9). AREG,
EREG, and BTC belong to the family of EGF-like growth
factors synthesized as integral membrane precursors. The li-
gands are shed from the cell surface by proteolytic cleavage of
the ectodomain and bind to homo- or heterodimers of the
EGF receptor (EGFR) family of receptor tyrosine kinases (18,
58). AREG binds specifically to EGFR (also called ERBB1),
while EREG and BTC can bind both EGFR and ERBB4 (19,
42, 43). Importantly, data from culture systems have docu-
mented that occupancy of G protein-coupled receptors
(GPCRs) often leads to shedding of EGF-like growth factors
and transactivation of EGFRs (13, 38, 46, 51).
Most of the current data on EGF-like growth factor actions
in the ovary are derived from in vitro studies. In cultured
preovulatory follicles, exogenous AREG or EREG induces
oocyte maturation as efficiently as LH, whereas BTC is only
partially effective (34). In vitro, AREG, EREG, and BTC each
induce the expression of Ptgs2 (prostaglandin synthase-2 or
cyclooxygenase-2 [COX2]), Tnfaip6 (tumor necrosis factor al-
pha-induced protein [Tnfaip6]), and Has2 (hyaluronan syn-
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thase 2 [HAS2]), genes that are necessary for synthesis and
stabilization of the extracellular matrix by cumulus cells, and
are potent stimulators of cumulus expansion. Cultured COCs
expand in response to direct stimulation by the EGF-like fac-
tors but not by LH. Inhibition of EGFR tyrosine kinase activity
by AG1478 blocks LH-induced oocyte maturation and cumulus
expansion in cultured follicles. Together, these studies strongly
suggest that these EGF-like growth factors are sufficient to
promote many of the LH effects in vitro.
Nevertheless, a physiological role for these growth factors in
vivo has not been established. Mice null for either Areg or Ereg
have been previously reported to be fertile (21, 26). Mice null
for Egfr die at peri-implantation, at mid-gestation, or soon
after birth, depending on the strain, thus precluding analysis of
fertility (50, 52). Mice that express a hypomorphic allele of
Egfrwa2 (waved-2) are viable, but an effect on fertility is con-
troversial (8, 25). Egfrwa2 homozygous mice that express a
receptor with reduced tyrosine kinase activity due to a single
amino acid substitution in the kinase domain (V743G) have
been considered fertile. In other reports, although reduced
litter sizes have been described for the Egfrwa2 homozygous
mice, this was thought to be due to impaired glial cell control
of LH-releasing hormone secretion (39). Therefore, evidence
for a physiological role of this signaling network in LH-induced
ovulation in vivo is lacking.
To determine the involvement of the EGF network in LH-
induced ovulation, we have investigated the effect of single and
multiple disruptions of the EGF network on events preceding
and following the time of ovulation in mice in a controlled
model of hormone-induced follicle maturation. Because dou-
ble or triple knockouts for Areg, Ereg, and Btc would be difficult
to produce due to the tight linkage of the three genes on the
same chromosome (36), alternative approaches were sought to
further disrupt the EGF network in mice. To this end, double-
mutant mice null for Areg and homozygous for the Egfrwa2
allele were generated (Areg/ Egfrwa2/wa2). Here, we provide
genetic evidence that LH-induced oocyte reentry into the mei-
otic cell cycle, expression of specific genes during somatic cell
differentiation, and ovulation are all dependent on efficient
activation of signaling through the EGFR.
MATERIALS AND METHODS
Animals and hormone treatments. Amphiregulin-null (Areg/) mice (C57BL/6J 
129Sv) were generated in the laboratory of David C. Lee (21, 26). Epiregulin-null
mice (Eregtm1Dwt, herein referred to as Ereg/) (21, 26) and Egfrwa2 mice
(C57BL/6J) were developed in the laboratory of David W. Threadgill. Areg/
mice were mated with wa2 heterozygous mice to generate double heterozygous
mice (Areg/ Egfrwa2/). Double heterozygous mice were then mated to pro-
duce offspring of the desired genotypes (Areg/ Egfr/, Areg/ Egfrwa2/wa2,
Areg/ Egfrwa2/wa2).
Areg/ mice were genotyped by PCR analysis using specific primers: AR-F1
(5-CTTTCCAGCTTTCTCCACCTCAAG-3), AR-R1 (5-ACAGTAACCTCT
GTTGCATGCCAC-3), and PGK2 (5-CTGCACGAGACTAGTGAGACGTG
C-3). The sizes for the Areg wild-type (WT) (AR-F1/AR-R1) and null (AR-F1/
PGK2) PCR-amplified products are 330 bp and 600 bp, respectively. Reverse
transcription-PCR (RT-PCR) analysis using Areg-specific primers (34) confirmed
the absence of Areg mRNA in Areg/ ovaries. Egfrwa2 mice were genotyped by
PCR amplification of the region containing the point mutation that results in a
valine to glycine substitution at residue 743 by use of the specific primer pair
Wa2-F (5-TACCCAGAAAGGGATATGCG-3) and Wa2-R (5-GGAGCCA
ATGTTGTCCTTGT-3). The PCR product was digested with the FokI restric-
tion enzyme to detect the mutation (Egfr/, 230 bp; Egfrwa2/wa2, 100 bp and
130 bp).
Immature female mice (22 to 24 days old) were injected intraperitoneally with
5 IU of pregnant mare serum gonadotropin (PMSG; Calbiochem, La Jolla, CA)
to stimulate ovarian follicular growth to the preovulatory stage. After 44 h, mice
were injected intraperitoneally with an ovulatory dose of 5 IU of hCG (Sigma-
Aldrich, St. Louis, MO) (17). Ovaries were isolated at selected times after
hormone priming and processed for histological analyses or were used as de-
scribed below and in the figure legends. For histological analyses, ovaries were
fixed in Bouin’s fixative (Polysciences, Inc., Warrington, PA) overnight at 4°C,
dehydrated and embedded in paraplast, sectioned serially at 6 m onto Super-
frost Plus slides (Fisher Scientific, Pittsburgh, PA), stained with hematoxylin and
eosin, and analyzed by light microscopy. For superovulation experiments, oocytes
were recovered from the oviducts 13 to 14 h or 22 to 24 h after hCG and counted
(17). Superovulated ovaries were also fixed as described above for histological
analyses. Because the numbers of ovulated oocytes for a given genotype did not
differ at either time point, the data were pooled. All animals were treated in
accordance with the guidelines of the Stanford University Administrative Panel
on Laboratory Animal Care.
Evaluation of oocyte meiotic resumption. Ovaries were isolated from imma-
ture female mice 0, 1, 2, 3, 4, and 5 h after hCG stimulation in vivo and placed
in Liebovitz’s L-15 medium (Invitrogen, Grand Island, NY) containing 5% fetal
bovine serum (Invitrogen) and 100 U penicillin and 100 g streptomycin (Sigma-
Aldrich) (L-15 complete medium). Preovulatory follicles were punctured using
26-1/2-gauge needles (Becton Dickinson & Co., Franklin Lakes, NJ) to release
COCs. COCs were collected using a Drummond sequencing pipette, and oocytes
were denuded of cumulus cells by gentle repeat pipetting in a microcentrifuge
tube. COCs collected at 4 h or later were briefly cultured in L-15 complete
medium containing 1 g/ml hyaluronidase to facilitate denuding of oocytes.
Denuded oocytes were examined under a stereomicroscope for evidence of
dissolution of the oocyte nuclear membrane (a process called germinal vesicle
breakdown [GVBD]), a hallmark of oocyte meiotic resumption. Oocytes within
large antral follicles were also examined through serial sections of hematoxylin-
and eosin-stained ovaries fixed 9 h after hCG (see below) for GVBD. The
percentage of GVBD oocytes was recorded and averaged at each time point.
To determine the time course of spontaneous oocyte maturation in vitro,
COCs were released from Areg/ Egfr/ and Areg/ Egfrwa2/wa2 PMSG-
primed mouse ovaries by needle puncture and oocytes were denuded as de-
scribed above. Oocytes were cultured in 30-l droplets of L-15 complete medium
under mineral oil at 37°C in air and were examined at regular time intervals for
evidence of complete GVBD. The total number of oocytes that completed
GVBD was recorded at each time point and is reported as percent GVBD. The
time that oocytes were first released from preovulatory follicles by needle punc-
ture was designated time 0.
Evaluation of cumulus expansion. Mouse ovaries were isolated 9 h after hCG
stimulation, fixed in Bouin’s fixative (Polysciences Inc.), and processed as de-
scribed above. COCs within large antral follicles were examined through serial
sections of hematoxylin- and eosin-stained ovaries. A subjective 0 to 4 scoring
system was used to evaluate the degree of cumulus expansion for each complex
(55). Unexpanded complexes received a score of 0 to 1. Complexes in which
the outer layers of cumulus cells had begun to expand received a score of 2. A
score of 3 was indicative of complexes in which all layers except the corona
radiata (the layer immediately adjacent to the oocyte) had expanded, and max-
imally expanded complexes were scored 4. Ovaries from at least four mice were
analyzed for each genotype.
Semiquantitative RT-PCR. RNA was extracted from whole mouse ovaries by
use of TRIzol reagent (Invitrogen) and from COCs by use of an RNeasy Micro
kit (QIAGEN, Valencia, CA) as directed by the respective manufacturers. For
analysis of Ptgs2, Tnfaip6, and Has2 expression, the 3 h time point was selected
because increased expression of these genes was previously observed in cultured
ovarian follicles (33) and in cumulus cells (unpublished observations). Total
RNA (300 ng from whole ovaries and 100 ng from COCs) was reverse tran-
scribed using 1 thermocycle buffer, 3.75 mM MgCl2, 1 mM deoxynucleoside
triphosphates (Promega Corp., Madison, WI), 500 ng poly(dT) (Amersham
Pharmacia, Newark, NJ), and 2.5 U avian myeloblastosis virus–reverse transcrip-
tase (Promega Corp.) at 42°C for 75 min and 95°C for 5 min. After completion
of the RT reactions, 1/4 of each reaction was used for PCR amplification of the
genes of interest. The following were added: 0.1 M of each primer, 0.25 Ci
[32P]deoxy-CTP (Perkin Elmer, Boston, MA), and 0.625 U Taq polymerase in
1 thermocycle buffer–2 mM MgCl2 (Promega Corp.). PCR conditions were
94°C for 2 min followed by cycles of 94°C for 30 s, 60°C for 45 s, and 72°C for 1
min and a final extension at 72°C for 7 min. PCR amplifications using specific
primers were performed for the indicated number of cycles: Ptgs2 (COX2), 25
cycles (32); Tnfaip6 (Tnfaip6), 24 cycles (32); Has2 (HAS2), 28 cycles (6); Lhcgr
(LHR), sense, 25 cycles (6); and Rpl19 (L19), 20 cycles (35, 45). The amplified
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cDNA products were resolved on a 5% polyacrylamide gel and quantified using
a Storm 840 PhosphorImager and ImageQuant software (Molecular Dynamics,
Inc., Sunnyvale, CA).
Preovulatory follicle culture and cAMP radioimmunoassay. PMSG-primed
mouse ovaries were placed in L-15 complete medium, and preovulatory follicles
were microdissected under a stereomicroscope using fine forceps. The isolated
follicles were moved through fresh L-15 complete medium and three changes of
minimal essential medium (MEM) supplemented with 10% fetal bovine serum
(Invitrogen) and 100 U penicillin and 100 g streptomycin (Sigma-Aldrich).
Follicles were then cultured in 1 ml complete MEM sealed under conditions of
95% O2–5% CO2 in glass scintillation vials at 37°C. After equilibration, follicles
were cultured for 30 min in the absence or presence of 5 IU recombinant LH
(rLH) (Luveris; Serono, Rockland, MA). At the end of the incubation, follicles
were first transferred into 2 ml Dulbecco’s phosphate-buffered saline (DPBS)
with Ca2 and Mg2 containing 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-
Aldrich) and then moved into a small volume of DPBS–0.5 mM 3-isobutyl-1-
methylxanthine for needle puncture. Samples were collected in 1.5 ml Eppendorf
tubes and incubated for 5 min at 95°C, and then 1 ml 95% ethanol–0.1%
trichloroacetic acid was added. After 10 min centrifugation, supernatants were
transferred to new tubes, dried in a speed vacuum, and resuspended in 1 ml
DPBS. An aliquot of each sample was diluted in DPBS and acetylated, and cyclic
AMP (cAMP) content was measured by radioimmunoassay (14).
Immunoprecipitation and Western blot analyses. Preovulatory follicles from
PMSG-primed mouse ovaries were isolated in L-15 complete medium and cul-
tured in 1 ml complete MEM as described above. Thirty-five follicles per treat-
ment group were cultured in the absence or presence of rLH for 2 h. At the end
of the incubation, follicles were transferred into DPBS without Ca2 and Mg2
to remove residual medium. The follicles were then homogenized in 300 l of
ice-cold radioimmunoprecipitation assay buffer (50 mM Tris [pH 7.5], 150 mM
NaCl, 1% NP-40, 0.1% sodium dodecyl sulfate [SDS], 0.25% deoxycholic acid)
containing an EDTA-free protease inhibitor cocktail (Roche, Indianapolis, IN),
1 mM EDTA, 1 mM NaF, 1 mM sodium pyrophosphate, and 1 mM sodium
orthovanadate to extract proteins. After centrifugation for 5 min at maximum
speed at 4°C, the supernatants were collected and stored at 80°C.
Protein concentrations were quantified using a bicinchoninic acid protein assay
kit (Pierce, Rockford, IL). A constant amount of proteins was immunoprecipi-
tated with 4 g sheep polyclonal anti-EGFR antibody (Upstate, Lake Placid,
NY) overnight at 4°C. The next day, samples were incubated with protein
G-Sepharose for 3 h at 4°C and then washed twice in phosphate-buffered
saline containing protease inhibitors as described above. Proteins were eluted
from the immunoprecipitated pellet by resuspending in 3 SDS buffer and
boiling for 5 min.
Immunoprecipitated protein samples were run on an SDS-polyacrylamide
electrophoresis gel and transferred onto Immobilon-P membranes (Millipore
Corp., Bedford, MA) by electrophoresis. Membranes were blocked in 5% nonfat
dry milk (Bio-Rad, Hercules, CA) for 1 h at room temperature, washed in
Tris-buffered saline containing 0.1% Tween 20 (TBST), and incubated overnight
at 4°C with rabbit polyclonal anti-phospho-EGFR antibody (pY1068; Cell Sig-
naling Technology, Beverly, MA) diluted 1:1,000 in TBST containing 5% bovine
serum albumin. Next, the membranes were washed in TBST and then incubated
for 1 h at room temperature with anti-rabbit immunoglobulin peroxidase-linked
antibody (Amersham) diluted 1:40,000 in TBST containing 0.5% nonfat dry milk
(Bio-Rad). After membranes were washed in TBST, ECL Plus reagent (Amer-
sham) was used to detect the immunoreactive phospho-EGFR and the signal was
visualized by autoradiography.
The same membranes were incubated for 30 min at 37°C with agitation in a
solution containing 62.5 mM Tris (pH 6.8), 2% SDS, and 100 mM -mercapto-
ethanol to remove bound antibodies. After being washed in TBST and blocked
in 1% nonfat dry milk, membranes were incubated for 2 h at room temperature
with rabbit polyclonal anti-EGFR antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) diluted 1:200 in TBST containing 0.2% nonfat dry milk (Bio-Rad).
Next, membranes were washed in TBST, incubated for 1 h at room temperature
with anti-rabbit immunoglobulin G peroxidase-linked antibody (Amersham) di-
luted 1:5,000 in TBST containing 0.2% nonfat dry milk (Bio-Rad), and detected
as above.
In situ hybridization. A riboprobe in vitro transcription system kit (Promega)
was used to synthesize [35S]UTP-labeled antisense and sense RNA probes from
Ptgs2 and Cyp11a1 cDNAs that were subcloned in the pCR2-TOPO and pBlue-
script vectors, respectively. In situ hybridization was performed as previously
described (34).
Statistical analyses. All data are shown as the means  standard errors of the
means (SEM). Data were analyzed by one-way analysis of variance and Bonfer-
roni’s multiple comparison test or by Student’s t test where appropriate. P  0.05
was considered statistically significant.
RESULTS
Delayed onset of oocyte meiotic maturation and reduced
cumulus expansion in amphiregulin- and epiregulin-null fe-
male mice. To address the role of the EGF network in vivo, we
investigated how meiotic resumption and differentiation of so-
matic cells surrounding the oocyte proceed in genetic models
where the EGF network is progressively disrupted. To this aim,
immature female mice homozygously null for the Areg allele
(Areg/) or the Ereg allele (Ereg/) were primed with PMSG
to promote follicle development to the preovulatory stage.
After 44 h, mice were stimulated with hCG to induce terminal
differentiation and ovulation, and the responses that ensued
were investigated. In this model, normally oocyte meiotic resump-
tion occurs by 4 h, cumulus expansion by 9 h, and ovulation
approximately 12 h after hCG stimulation. This well-established
and extensively used model of exogenous administration of go-
nadotropins was chosen to avoid interference from any possible
extragonadal effects of the EGF network.
In wild-type and heterozygous (Areg/) littermates of
Areg/ mice, oocytes reenter the meiotic cell cycle between 2
and 4 h after hCG (Fig. 1A). In Areg/ mice, meiotic reentry
still occurs but with a delayed time course (Fig. 1A), suggesting
that the transfer of signals from the somatic to the germ cell
compartment occurs with decreased efficiency. By 9 h, most of
the oocytes in the Areg/ antral follicles had undergone
GVBD (Table 1). When oocytes in antral follicles of epiregu-
lin-null (Ereg/) mouse ovaries were monitored for meiotic
resumption 8 h after hCG, only 	60% of those examined had
resumed meiosis (Table 1).
The expression of genes important for cumulus matrix for-
mation and stability was examined in COCs from Areg/
ovaries collected 3 h after hCG and compared to that in COCs
from Areg/ mice. By semiquantitative RT-PCR, reduced ex-
pression of Ptgs2, Tnfaip6, and Has2 was detected in Areg/
COCs (Fig. 1B). This inefficient activation of genes involved in
matrix production was confirmed by visual scoring of the state
of expansion of the cumulus in vivo. COCs in preovulatory
follicles were examined through serial sections of hematoxylin-
and eosin-stained Areg/ and Areg/ mouse ovaries isolated
9 h after hCG. In Areg/ ovaries, the majority of COCs
examined appeared well expanded (Fig. 1C and D). However,
the degree of expansion for COCs from Areg/ ovaries was
reduced (Fig. 1C and D). A similar or more pronounced effect
was observed with the Ereg/ mice (Fig. 1D and data not
shown).
The results presented above indicate that removal of a single
EGF-like growth factor has an impact on events critical during
the periovulatory period. However, the effects are small and
disruption of meiotic resumption and cumulus expansion is
incomplete likely because of the redundancy in the EGF net-
work.
Development of ovarian follicles in the preovulatory stage in
Areg/ Egfrwa2/wa2 mice. To explore the possibility of a redun-
dant function, we investigated the effect of multiple defects in
the EGF network on events during ovulation. To further dis-
rupt the EGF network, Areg/ mice were bred to mice car-
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rying the hypomorphic Egfrwa2 allele to generate double-mu-
tant mice (Areg/ Egfrwa2/wa2). These mice were compared to
mice that were wild type with respect to the two alleles.
In view of the reports of extragonadal effects of the EGFR
(23, 39) and the possible impact of EGF on follicle develop-
ment (12, 29, 47), several paradigms were used to determine
whether early follicular development was affected in the
Areg/ Egfrwa2/wa2 mice. Double-mutant mice had no overt
defect in growth and viability, ovaries after PMSG priming
were of the normal size, and uteri appeared swollen, indicating
a normal steroidogenic output from the gonad (data not
shown). Ovaries from PMSG-primed Areg/ Egfrwa2/wa2 mice
appeared morphologically identical to those of wild-type con-
trols and contained follicles at different stages of development,
including many at the preovulatory stage (Fig. 2A). In these
antral follicles, the granulosa cell layer had thickness compa-
rable to wild-type controls. Moreover, oocytes isolated from
FIG. 1. Delayed onset of oocyte meiotic maturation and reduced cumulus expansion in Areg/ mice. (A) Time course of breakdown of the
oocyte nuclear membrane (GVBD) in wild-type and Areg/ mice. In vivo-stimulated ovaries were collected at the indicated times after hCG, and
large antral follicles were punctured to release the oocytes. Data are shown as means  SEM, and three to seven females were used at each time
point. The percentage of oocytes that resumed meiosis was significantly lower in Areg/ mice at 3 h and 4 h after hCG than in WT/Areg/ females.
(B) Pattern of gene expression in Areg/ COCs. Semiquantitative RT-PCR analysis was performed to evaluate Ptgs2, Tnfaip6, and Has2 mRNA
expression levels in COCs isolated from Areg/ and Areg/ mice stimulated with hCG for 3 h. Data are shown as the means  SEM of the relative
expression levels for Ptgs2, Tnfaip6, or Has2 normalized to Rpl19 (Areg/, n 
 7; Areg/, n 
 10). (C) Morphological analysis of cumulus
expansion in Areg/ mice. The degree of cumulus expansion was evaluated for COCs in preovulatory follicles of ovaries stimulated with hCG for
9 h by use of a subjective 0 to 4 scoring system (55). Ovaries from four different females were analyzed for each genotype. The data are shown
as means  SEM. *, P  0.001. (D) Histology of COCs in Areg
/ and Areg/ preovulatory follicles 9 h after hCG and Ereg/ follicles 8 h after
hCG. In these selected COCs, the metaphase spindle is visible in the oocytes. Areg/ COCs are well expanded, whereas COCs from Areg/ and
Ereg/ mice appear moderately or poorly expanded.












Areg/ 9 85 98.8  1.4
Areg/ 9 74 83.2  9.1
Ereg/ 8 45 62.2b
Areg/ Egfrwa2/wa2 9 79 29.3  14.1
Areg/ Egfrwa2/wa2 9 115 24.0  13.5
a For all mice except the Ereg/ mice, the percentage of oocytes that had
undergone GVBD was calculated for each mouse (n 
 4 except Areg/ Egfrwa2/wa2
mice, for which n 
 6) and averaged. Data are shown as means  SEM.
b The percentage of GVBD oocytes in Ereg/ ovaries was calculated by
dividing the number of oocytes in GVBD by the total number of oocytes exam-
ined in sections of ovaries from 10 mice. Because of the method of collection of
the specimens, percent GVBD for individual mice could not be assessed.
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preovulatory follicles of PMSG-primed Areg/ Egfrwa2/wa2
mouse ovaries underwent in vitro spontaneous maturation at a
rate similar to that seen with oocytes from wild-type mice (Fig.
2B), demonstrating that oocyte meiotic competence is normal
in these mice. By semiquantitative RT-PCR analysis, the re-
sults of induction of Lhcgr expression, a hallmark of granulosa
cell differentiation towards a preovulatory phenotype, were
comparable between PMSG-primed Areg/ Egfrwa2/wa2 and
wild-type ovaries (Fig. 2C). When preovulatory follicles were
cultured in the presence of rLH for 30 min, the increase in
cAMP induced in Areg/ Egfrwa2/wa2 follicles was comparable
to that in wild-type follicles (Fig. 2D). Taken together, these
findings demonstrate that disruption of the EGF network does
not produce detectable changes in the growth and initial dif-
ferentiation of somatic and germ cells of the follicle and that
the ability to respond to LH with an increase in cAMP is
retained.
Impaired EGFR transactivation by LH in double-mutant
mice. To examine the effect of LH on activation of the EGFR,
preovulatory follicles from wild-type (Areg/ Egfr/),
Areg/ Egfrwa2/wa2, or Areg/ Egfrwa2/wa2 mice were cultured
in the absence or presence of rLH for 2 h. Immunoprecipita-
tion and Western blot analyses were performed to detect
EGFR phosphorylation. LH induced a progressive increase in
EGFR phosphorylation in wild-type follicles, with a maximum
reached after 2 h of stimulation (Fig. 3A and data not shown).
However, EGFR phosphorylation levels were reduced by more
than 50% in Areg/ Egfrwa2/wa2 follicles by comparison and
FIG. 2. Development of ovarian follicles up to the preovulatory stage in Areg/ Egfrwa2/wa2 mice. (A) Histological analyses of PMSG-primed
Areg/ Egfrwa2/wa2 mouse ovaries showed that many large antral follicles develop in response to the hormone stimulation. (B) Spontaneous
maturation of oocytes (scored as percent GVBD) isolated from preovulatory follicles of PMSG-primed Areg/ Egfrwa2/wa2 mice occurs in culture
in vitro at a rate similar to that seen with wild-type oocytes (n 
 4 for each genotype). (C) Similar levels of Lhcgr mRNA are expressed in Areg/
Egfrwa2/wa2 and wild-type ovaries as determined by semiquantitative RT-PCR. Data are means  SEM of the relative expression levels for Lhcgr
normalized to Rpl19 (n 
 3 for each genotype). (D) Preovulatory follicles from Areg/ Egfrwa2/wa2 mice cultured in the presence of rLH for 30
min respond with a normal increase in cAMP. Data represent the means  SEM of the results of three separate experiments.
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were further decreased in Areg/ Egfrwa2/wa2 follicles, with
only 	20% of that detected in the wild-type follicles (Fig. 3A).
Thus, a major disruption in LH-induced transactivation of the
EGFR was indeed present in the mutant mice. When double-
mutant follicles were incubated with high doses of EREG and
AREG, tyrosine phosphorylation of EGFR was restored to
wild-type levels (data not shown), suggesting that a supraphysi-
ological signal is able to partially restore the response of the
mutated EGFR.
Impaired oocyte meiotic resumption in mice with disrupted
EGFR signaling. Double-mutant immature mice were primed
with PMSG, and the effect of hCG on oocyte meiosis was
monitored at 4 h after injection, a time when significant effects
were detected in the Areg/ mice. In the double mutants,
most of the oocytes (90%) had not resumed meiosis (Fig. 3B).
Furthermore, this loss of function was proportional to the
disruption of the EGF network, as Areg/ oocytes were the
least affected, Areg/ Egfrwa2/wa2 oocytes showed a greater
than 50% decrease in GVBD, and combination of the two
lesions produced the maximal effect (Fig. 3B). By 9 h post-
hCG, only 	25% of the double-mutant oocytes examined had
resumed meiosis (Table 1), demonstrating that major disrup-
tion of EGFR signaling prevents signaling for oocyte matura-
tion. This in vivo finding was confirmed by culture of preovu-
latory follicles from the Areg/ Egfrwa2/wa2 mice. Stimulation
with rLH failed to induce GVBD in oocytes from these follicles
(0 oocytes out of 21 monitored). Conversely, exposure of these
follicles to high concentrations of AREG and EREG induced
maturation of approximately 50% of the oocytes (data not
shown).
Decreased gene expression and expansion of cumulus oocyte
complexes in Areg/ Egfrwa2/wa2 mouse ovaries. When the
expression of Ptgs2, Tnfaip6, and Has2 was examined in COCs
isolated 3 h after hCG from wild-type and Areg/ Egfrwa2/wa2
mice by semiquantitative RT-PCR analyses, the mRNA levels
for these genes were found to be greatly decreased in the
double mutants (Fig. 4A). Ptgs2 mRNA localization was exam-
ined further by in situ hybridization in mouse ovaries stimu-
lated with hCG for 3 h. Decreased signal was observed in the
mural granulosa cells and was below the threshold of detection
in cumulus cells of double-mutant preovulatory follicles com-
pared to the high signal detected in both cellular compart-
ments in wild-type preovulatory follicles (Fig. 4B). The failure
to express Ptgs2, Tnfaip6, and Has2 in COCs is consistent with
the morphological analysis of the degree of cumulus expansion
at 9 h after in vivo hCG injection. In contrast to the well-
expanded COCs observed in wild-type mouse ovaries (not
shown) or Areg/ mouse ovaries (Fig. 1C and 1D; included in
Fig. 4C for comparison), COCs in Areg/ Egfrwa2/wa2 preovu-
latory follicles were mostly unexpanded or poorly expanded
(Fig. 4C and 4D).
Impaired ovulation and luteinization in Areg/ Egfrwa2/wa2
females. To determine the in vivo effect of disrupted signaling
through the EGFR on ovulation, PMSG-primed mice were
stimulated with hCG to induce ovulation of oocytes. After 13
to 24 h, the oviducts were carefully opened to release the
ovulated cluster of COCs. Areg/ females released numbers
of oocytes (Fig. 5A) into the oviducts similar to those seen with
wild-type and Areg/ littermates (WT/Areg/, 40  10.56,
n 
 5). Interestingly, immature Ereg/ mice ovulated few
oocytes (Fig. 5A) in comparison to wild-type and Ereg/ lit-
termates (WT/Ereg/, 46.15  3.93, n 
 20) when superovu-
lated. Conversely, there was no statistically significant dif-
ference between adult Ereg/ and wild-type females in
ovulation rates after natural matings (data not shown). Very
few or no oocytes could be recovered from the oviducts of
Areg/ Egfrwa2/wa2 and Areg/ Egfrwa2/wa2 mice (Fig. 5A).
FIG. 3. Impaired EGFR activation and oocyte meiotic resumption
in Areg/ Egfrwa2/wa2 mice. (A) LH-induced EGFR phosphorylation
in Areg/ Egfr/, Areg/ Egfrwa2/wa2, and Areg/ Egfrwa2/wa2 pre-
ovulatory follicles. Proteins extracted from follicles cultured in the
absence or presence of 5 IU rLH for 2 h were immunoprecipitated
using an anti-EGFR antibody, and Western blotting was performed
using an EGFR-specific phosphoantibody. To control for protein load-
ing, the same membrane was reprobed using an anti-EGFR antibody.
Data represent the means  SEM of the results of three separate exper-
iments. P  0.05 compared to wild-type (a) and Areg/ Egfrwa2/wa2 (b)
mouse results. A representative blot is shown. (B) Resumption of
oocyte maturation (scored as GVBD) after 4 h hCG stimulation in
vivo was evaluated for immature mice of the indicated genotypes.
Results represent the means  SEM of the results for each group.
The number of mice per group is indicated above each bar. The
letters a and b correspond to P  0.05 and P  0.001, respectively,
compared to wild-type results, and c indicates P  0.05 compared to
Areg/ results.
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On the rare occasion in which ovulated oocytes were de-
tected in the mutant mice, most complexes appeared poorly
expanded or compact in comparison to the well-expanded
complexes from wild-type mice (Fig. 5B).
Histological analyses of the ovaries from the superovulated
double-mutant females revealed the presence of large antral
follicles, many containing entrapped, compact COCs with
oocytes still in the GV stage (data not shown). In the few
follicles that had ovulated, terminal differentiation (luteiniza-
tion) of somatic cells appeared normal, with an increase in
cytoplasmic volume associated with increased steroidogenic
capacity of luteinized cells and vascularization of the newly
formed corpus luteum (not shown). Moreover, at 48 h after
hCG, a time when corpora lutea are typically fully formed in
wild-type ovaries, few fully luteinized structures were observed
in the Areg/ Egfrwa2/wa2 ovaries. Double-mutant ovaries con-
tained many antral follicles that morphologically did not ap-
pear luteinized or that appeared partially luteinized with en-
trapped oocytes surrounded by compact cumuli (Fig. 5C). In
situ hybridization analysis of Cyp11a1 expression and localiza-
tion was performed to confirm the differentiation of somatic
cells into luteal cells. Cyp11a1 encodes the P450 cholesterol
side-chain cleavage enzyme that is highly expressed by luteal
cells for the synthesis of progesterone. Consistent with the
above-described histology, Cyp11a1 expression was detected in
partially luteinized and luteinized structures but not in granu-
losa cells of antral follicles that had not undergone terminal
differentiation (Fig. 5D). Cyp11a1 expression was detected in
the theca cell layers surrounding nonluteinized antral follicles.
Detailed analyses of fecundity and fertility were not per-
formed for the Areg/ Egfrwa2/wa2 mice, since interpretation
of the results might be complicated by potential extragonadal
FIG. 4. Defective cumulus expansion in Areg/ Egfrwa2/wa2 mice. (A) Semiquantitative RT-PCR results show significantly decreased expression
levels for Ptgs2, Tnfaip6, and Has2 in COCs from Areg/ Egfrwa2/wa2 mouse ovaries 3 h after hCG compared to wild-type control results. Data
represent means  SEM of the expression levels for Ptgs2, Tnfaip6, or Has2 normalized to Rpl19 (n 
 3 for each genotype). (B) In situ
hybridization analysis shows high expression and localization of Ptgs2 mRNA in mural granulosa cells (GC) and cumulus cells (CC) of preovulatory
follicles from wild-type ovaries 3 h after hCG (a and b). The signal is decreased in GCs and is below the threshold of detection in CCs of Areg/
Egfrwa2/wa2 follicles (c and d) (Oo, oocyte). (C) The degree of cumulus expansion for COCs in Areg/ Egfrwa2/wa2 mouse ovaries 9 h after hCG
was evaluated as described in Materials and Methods. A large proportion of COCs were poorly expanded or unexpanded. Data represent the mean
percentage of COCs scored  SEM (n 
 4 females; *, P  0.001). The degree of cumulus expansion in Areg
/ mice (see Fig. 1C) is included
for comparison. (D) Histology of COCs with GV and GVBD oocytes (left and right panels, respectively) from Areg/ Egfrwa2/wa2 mouse ovaries
9 h after hCG.
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FIG. 5. Impaired ovulation and luteinization in Areg/ Egfrwa2/wa2 mice. (A) Superovulation of wild-type and mutant mice. Ereg/, Areg/
Egfrwa2/wa2, and Areg/ Egfrwa2/wa2 mice ovulated significantly fewer oocytes than wild-type and Areg/ females. The number of females used per
group is indicated in parentheses above the bars. Data represent means  SEM; * indicates P  0.001 compared to either wild-type (Areg
/
Egfr/) or Areg/ values. (B) Images of ovulated COCs produced using Hoffman interference microscopy. Panels a and b show ovulated,
well-expanded complexes from a representative wild-type mouse. In contrast, both expanded and poorly expanded complexes were observed in the
few COCs that were ovulated by Areg/ Egfrwa2/wa2 mice (c; at higher magnification in panel d). Structures resembling ovulated COCs from
Areg/ Egfrwa2/wa2 mice (e and f) appeared poorly expanded. (C) Histology of Areg/ Egfrwa2/wa2 ovaries 48 h after hCG stimulation. Many antral
follicles contain entrapped, unexpanded COCs (panels a and c) with oocytes still in the GV stage (shown at higher magnification in panels b and
d). Somatic cells from antral follicles appeared either nonluteinized (a and b) or partially luteinized (c and d), with morphologically nonluteinized
granulosa cells (black arrows) lining the antrum and luteal cells (white arrows) in the outer cell layers. The asterisks mark entrapped GV oocytes.
(D) In situ hybridization analysis localizes Cyp11a1 mRNA in the corpora lutea of a wild-type ovary (a and b) and in luteinized cells of antral
follicles from an Areg/ Egfrwa2/wa2 ovary (c and d) 48 h after hCG stimulation. Signal for Cyp11a1 is absent from non-terminally differentiated
somatic cells.
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defects in adult mice, i.e., the regulation of LH-releasing hor-
mone release from the hypothalamic-pituitary axis (23, 39).
Nevertheless, it should be noted that one adult double-mutant
female gave birth to two small litters in the first 2 months of
mating (four and three pups, respectively) but produced no
additional litters over the following 6 months. A second adult
female produced two small litters (three pups and one pup,
respectively), while a third female had no litters, after 4.5 and
6 months of mating, respectively. Thus, a major disruption in
fecundity and perhaps fertility was likely present in these mice.
When wild-type and Areg/ female mice were mated with
wild-type males over a 6-month period, a small but significant
decrease in the average number of pups born per litter was
observed for the Areg/ females compared to wild-type fe-
males (5.97  0.36 pups/litter, n 
 5, and 7.83  0.29 pups/
litter, n 
 6, respectively; P  0.001). The average numbers of
litters born per month were not significantly different between
Areg/ (1.03  0.07, n 




With this report, we provide conclusive evidence that LH-
induced activation of EGFR signaling is essential for regulation of
oocyte maturation and cumulus cell functions. Progressive ge-
netic disruption of the EGF network in the periovulatory fol-
licle prevents LH induction of oocyte meiotic reentry and tran-
scription of genes involved in cumulus expansion. More
importantly, ovulation is compromised when growth factor
production and EGFR signaling is disrupted. Finally, the ge-
netic model that we have established indicates that activation
of the EGF network affects mural granulosa cells as well as the
transfer of the signal to cumulus cells, demonstrating both
autocrine and paracrine roles for these growth factors in the
ovulatory follicle.
In immature mice deficient in the AREG ligand, oocyte
meiotic resumption and cumulus expansion are delayed or
reduced. Although immature Areg/ females released num-
bers of oocytes into the oviducts similar to those seen with
wild-type females when superovulated, adult Areg/ female
mice produced fewer pups per litter than wild-type females,
demonstrating that removal of a single ligand is sufficient to
impact fertility. Because the disruption of fertility in Areg/
mice is modest, it is likely that redundancy of other EGF-like
growth factors compensates for the loss of AREG production.
Interestingly, Ereg ablation appears to have a larger impact on
oocyte maturation and ovulation in hormone-primed imma-
ture mice than Areg ablation. This may be due in part to
differences in the genetic backgrounds of the mice, Ereg/
mice being on a C57BL/6J background while Areg/ and
Areg/ Egfrwa2/wa2 mice are on a mixed background
(C57BL/6J  129Sv). It is also possible that the divergent
effects are due to the activities of the two ligands or to the fact
that EREG interacts with both EGFR and ERBB4 whereas
AREG interacts only with EGFR (19, 43). Although a role for
ERBB4 cannot be ruled out, the significantly reduced ovula-
tion rates in Areg/ Egfrwa2/wa2 and Areg/ Egfrwa2/wa2 mice
strongly suggests that the EGFR is the predominant receptor
involved.
In immature Areg/ Egfrwa2/wa2 mice, more pronounced
disruption of ovarian function is observed. Although antral
follicles appear to develop normally, respond to LH with a
robust increase in cAMP accumulation, and contain oocytes
that are competent to undergo spontaneous maturation, trans-
fer of the LH signal to the oocyte for induction of oocyte
maturation is prevented in these mice. In the double mutants,
LH-induced EGFR phosphorylation is significantly decreased
compared to wild-type results, suggesting that this phosphory-
lation is critical for translation of the LH signal into oocyte
meiotic resumption. Whereas the presence of EGFR in oo-
cytes is debated, several experiments suggest that transactiva-
tion of EGFR occurs in the cumulus cells (11, 40). Indeed,
EGF-like growth factors induce oocyte maturation in COCs
but have no effect on denuded oocytes (5, 34). Thus, impaired
EGFR signaling likely precludes transfer of a signal from cu-
mulus cells to the oocyte, although direct signaling cannot be
excluded at this stage. The nature of this signal is at present
unknown. Recent findings have implicated a class of GPCRs
belonging to the lipid receptor subfamily with constitutive ac-
tivity in the maintenance of meiotic arrest in oocytes (15, 20a,
28). Several studies indicate that EGF has profound effects on
lipid metabolism and signaling (2, 22). Thus, it is possible that
the signal emanating from the EGFR involves modulation of
the activity of these GPCRs.
Cumulus expansion is greatly impaired in the double-mutant
mice. Significantly reduced expression of Ptgs2, Tnfaip6, and
Has2, genes important for formation and stabilization of the
cumulus matrix, in COCs of Areg/ Egfrwa2/wa2 mice precedes
and is consistent with the observed defects in cumulus expan-
sion. These findings document that cumulus cell activation
does not occur in the absence of a functional EGF network. By
in situ hybridization, signal for Ptgs2 mRNA is notably de-
creased in both mural granulosa and cumulus cells of preovu-
latory follicles in Areg/ Egfrwa2/wa2 mouse ovaries 3 h after
hCG. This observation indicates that LH induction of Ptgs2
expression is dependent on activation of EGFR signaling not
only in cumulus cells but also in mural granulosa cells. Thus,
EGF-like growth factor signaling through the EGFR appears
to have both autocrine and paracrine roles in transducing LH
effects in the preovulatory follicle for ovulation. Recently, an
increase in Areg and Ereg mRNAs has been detected 4 to 8 h
after hCG stimulation in the cumulus (49). This induction is
reduced in Ptgs2-null mice and is in part induced by AREG
itself. Therefore, it is likely that the autocrine loop activating
Ptgs2 expression in mural granulosa cells, which is required for
prostaglandin production, contributes to the propagation of
the stimulus to cumulus cells. Thus, a positive feedback further
amplifies the effect of these growth factors, extending the du-
ration of activation in the cumulus.
Ovulation is compromised in the Areg/ Egfrwa2/wa2 and
Areg/ Egfrwa2/wa2 mice. This is documented by the results
showing that few or no oocytes were recovered from the ovi-
ducts and by the concomitant observation of entrapped oocytes
in follicles 24 to 48 h after hCG. The rare follicles that were
able to ovulate appeared to be fully luteinized, suggesting
that a subset of follicles is able to escape the EGF network
disruption, a finding consistent with the residual fertility and
fecundity of the double-mutant mice. This may be due to the
incomplete inactivation of Egfrwa2 or utilization of compen-
satory pathways in a subset of follicles similar to what was
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observed in a subset of intestinal tumors arising in an
Egfrwa2 homozygous background (44). Additional caution
should be used in interpreting the data, because disruption
in the hypothalamic-pituitary axis has been described for
Egfrwa2 and astroglial cell-specific EGFR mutant mice (23,
39). Therefore, decreased fertility in adult females may be
due to ovarian and/or extraovarian defects.
In superovulated Areg/ Egfrwa2/wa2 mice, the majority of
antral follicles were unruptured, with entrapped GV oocytes
surrounded by compact cumulus cells and partial or no lutein-
ization of somatic cells. The few COCs that were ovulated
displayed defective cumulus expansion. Follicle rupture may be
the most sensitive event, because it requires many cooperating
steps to occur. Remodeling of the extracellular matrices, the
cell layers in the follicle wall, and the ovarian surface epithe-
lium at the apex of the follicle is required for follicle rupture
(31, 41, 53). Constriction of a layer of smooth-muscle cells in
the follicular wall at the time of rupture is also likely important
(20). In addition, in mouse models with impaired cumulus
expansion, follicle rupture is impaired though not always com-
pletely abolished depending on the model (3, 10, 16, 33, 56, 57)
and as observed here. Previous attempts to define the effect of
the EGF network in vivo by intrabursal injection of an EGFR
kinase inhibitor provided an initial clue to the role of this
network in follicle rupture (1). However, at high doses of
inhibitor, no significant effect on ovulation was observed. Here,
our studies demonstrate the critical role of the EGF network in
ovulation using a genetic approach. We propose that defective
follicle rupture may be due in part to the greatly reduced
expression of Ptgs2, and likely other genes, in the follicle.
Indeed, the phenotype of the Areg/ Egfrwa2/wa2 mice resem-
bles that of Ptgs2-null mice (4, 24) that are anovulatory and
that have few or no corpora lutea. Nrip1 (previously known as
RIP140)-null mice that display decreased expression of the
EGF-like growth factors Ptgs2, Tnfaip6, and Has2 also have
impaired cumulus expansion and follicle rupture (54). Simi-
larly, a defect in gene expression and follicle rupture has been
previously reported in the Pde4d-null mice (33) together with
a decrease in EGF-like growth factor induction (34). However,
both genetic mouse models exhibit normal oocyte maturation
and luteinization, in contrast to the Areg/ Egfrwa2/wa2 mouse
results. Why oocyte maturation and luteinization are not dis-
rupted in Nrip1- and Pde4d-null mice is unclear. It is possible
that the residual activity of a wild-type EGFR in follicular cells
is sufficient to support these processes.
Taken together, the findings presented above demonstrate
that LH induction of EGF-like growth factors and activation of
EGFR signaling is essential for ovulation of mature oocytes
and somatic cell terminal differentiation. To our knowledge,
this is the first in vivo demonstration that a critical physiolog-
ical process such as ovulation is dependent on GPCR transac-
tivation of EGFR signaling. It also establishes a paradigm
whereby LH actions are propagated by activation of the EGF
network, which in turn acts in an autocrine and paracrine
fashion within this functional unit of the ovary. These findings
have important implications for the development of new strat-
egies for the control of fertility and for the improvement of in
vitro culture conditions for the maturation of oocytes and
follicles.
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